Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Apr;91(4):1396–1398. doi: 10.1172/JCI116342

Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis.

J N Basile 1, Y Liel 1, J Shary 1, N H Bell 1
PMCID: PMC288112  PMID: 8386185

Abstract

Ca absorption is regulated by 1,25(OH)2D, and serum values vary inversely with Ca intake. In sarcoidosis, 1,25(OH)2D is produced by alveolar macrophages in response to gamma-interferon, and patients may develop hypercalcemia after prolonged exposure to sunlight and increased dermal production of vitamin D3. To determine if increased Ca intake suppresses serum 1,25(OH)2D in normocalcemic patients and to identify those at risk, 17 normal subjects and 11 patients were studied on a metabolic ward for two and one-half days while receiving first 400 and then 1,000 mg/d of Ca. On the low Ca intake, serum angiotensin-converting enzyme (ACE), an index of disease activity, was higher in only three of the patients than in the controls, mean serum 1,25(OH)2D was higher in the patients, and mean serum total Ca, serum Ca++, and urinary Ca were not different in the two groups. On the higher Ca intake, mean urinary Ca increased in both groups, but mean serum 1,25(OH)2D was suppressed only in the normal subjects. Thus, 1,25(OH)2D production is abnormally regulated, indicating that (a) normocalcemic patients with sarcoidosis are at risk for developing abnormal Ca metabolism, and (b) a better index of disease activity is provided by the oral Ca suppression test than by serum ACE.

Full text

PDF
1396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. S., Gacad M. A. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med. 1985 Apr 1;161(4):755–765. doi: 10.1084/jem.161.4.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams J. S., Sharma O. P., Gacad M. A., Singer F. R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983 Nov;72(5):1856–1860. doi: 10.1172/JCI111147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adams N. D., Gray R. W., Lemann J., Jr The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 1979 Jun;48(6):1008–1016. doi: 10.1210/jcem-48-6-1008. [DOI] [PubMed] [Google Scholar]
  4. BELL N. H., GILL J. R., Jr, BARTTER F. C. ON THE ABNORMAL CALCIUM ABSORPTION IN SARCOIDOSIS. EVIDENCE FOR INCREASED SENSITIVITY TO VITAMIN D. Am J Med. 1964 Apr;36:500–513. doi: 10.1016/0002-9343(64)90099-3. [DOI] [PubMed] [Google Scholar]
  5. Baginski E. S., Marie S. S., Clark W. L., Zak B. Direct microdetermination of serum calcium. Clin Chim Acta. 1973 Jun 14;46(1):49–54. doi: 10.1016/0009-8981(73)90101-0. [DOI] [PubMed] [Google Scholar]
  6. Bartels H., Böhmer M. Eine Mikromethode zur Kreatininbestimmung. Clin Chim Acta. 1971 Mar;32(1):81–85. doi: 10.1016/0009-8981(71)90467-0. [DOI] [PubMed] [Google Scholar]
  7. Bell N. H., Stern P. H., Pantzer E., Sinha T. K., DeLuca H. F. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest. 1979 Jul;64(1):218–225. doi: 10.1172/JCI109442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Belsey R. E., DeLuca H. F., Potts J. T., Jr A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J Clin Endocrinol Metab. 1974 Jun;38(6):1046–1051. doi: 10.1210/jcem-38-6-1046. [DOI] [PubMed] [Google Scholar]
  9. Broadus A. E., Insogna K. L., Lang R., Ellison A. F., Dreyer B. E. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med. 1984 Jul 12;311(2):73–80. doi: 10.1056/NEJM198407123110201. [DOI] [PubMed] [Google Scholar]
  10. Brumbaugh P. F., Haussler M. R. 1 Alpha,25-dihydroxycholecalciferol receptors in intestine. II. Temperature-dependent transfer of the hormone to chromatin via a specific cytosol receptor. J Biol Chem. 1974 Feb 25;249(4):1258–1262. [PubMed] [Google Scholar]
  11. Daly J. A., Ertingshausen G. Direct method for determining inorganic phosphate in serum with the "CentrifiChem". Clin Chem. 1972 Mar;18(3):263–265. [PubMed] [Google Scholar]
  12. DeRemee R. A., Lufkin E. G., Rohrbach M. S. Serum angiotensin-converting enzyme activity. Its use in the evaluation and management of hypercalcemia associated with sarcoidosis. Arch Intern Med. 1985 Apr;145(4):677–679. doi: 10.1001/archinte.145.4.677. [DOI] [PubMed] [Google Scholar]
  13. DeSimone D. P., Brilliant H. L., Basile J., Bell N. H. Granulomatous infiltration of the talus and abnormal vitamin D and calcium metabolism in a patient with sarcoidosis: successful treatment with hydroxychloroquine. Am J Med. 1989 Dec;87(6):694–696. doi: 10.1016/s0002-9343(89)80409-7. [DOI] [PubMed] [Google Scholar]
  14. Gallagher J. C., Riggs B. L., Eisman J., Hamstra A., Arnaud S. B., DeLuca H. F. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest. 1979 Sep;64(3):729–736. doi: 10.1172/JCI109516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Garabedian M., Holick M. F., Deluca H. F., Boyle I. T. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1673–1676. doi: 10.1073/pnas.69.7.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gray R. W., Wilz D. R., Caldas A. E., Lemann J., Jr The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 1977 Aug;45(2):299–306. doi: 10.1210/jcem-45-2-299. [DOI] [PubMed] [Google Scholar]
  17. Hughes M. R., Baylink D. J., Jones P. G., Haussler M. R. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest. 1976 Jul;58(1):61–70. doi: 10.1172/JCI108459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hulter H. N., Halloran B. P., Toto R. D., Peterson J. C. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism. J Clin Invest. 1985 Aug;76(2):695–702. doi: 10.1172/JCI112023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lambert P. W., Hollis B. W., Bell N. H., Epstein S. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. J Clin Invest. 1980 Oct;66(4):782–791. doi: 10.1172/JCI109916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Portale A. A., Halloran B. P., Murphy M. M., Morris R. C., Jr Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest. 1986 Jan;77(1):7–12. doi: 10.1172/JCI112304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reichel H., Koeffler H. P., Barbers R., Norman A. W. Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab. 1987 Dec;65(6):1201–1209. doi: 10.1210/jcem-65-6-1201. [DOI] [PubMed] [Google Scholar]
  22. Reinhardt T. A., Horst R. L., Orf J. W., Hollis B. W. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab. 1984 Jan;58(1):91–98. doi: 10.1210/jcem-58-1-91. [DOI] [PubMed] [Google Scholar]
  23. Stern P. H., De Olazabal J., Bell N. H. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest. 1980 Oct;66(4):852–855. doi: 10.1172/JCI109924. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES